Alembic Pharmaceuticals Limited (NSE:APLLTD)
902.75
+7.00 (0.78%)
May 14, 2025, 9:30 AM IST
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 14,858 employees as of March 31, 2024. The number of employees increased by 265 or 1.82% compared to the previous year.
Employees
14,858
Change (1Y)
265
Growth (1Y)
1.82%
Revenue / Employee
4.49M INR
Profits / Employee
392.66K INR
Market Cap
176.07B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Alembic Pharmaceuticals News
- 7 days ago - Alembic Pharma Q4 profit falls 12%, revenue rises 17% - The Times of India
- 7 days ago - Alembic Pharmaceuticals shares drop 2% as Q4 net profit falls 11.9% YoY to Rs 156.89 crore - Business Upturn
- 7 days ago - Alembic Pharmaceuticals Q4 Results: Revenue rises 16.7% YoY to ₹1,769 crore, Net profit down 11.96% YoY - Business Upturn
- 11 days ago - Alembic Pharma gets USFDA final nod for Ticagrelor 90 mg, tentative approval for 60 mg - Business Upturn
- 14 days ago - Alembic Pharma share price jumps 3% after USFDA issues EIR from for Panelav plant - Business Upturn
- 14 days ago - Stocks to watch today: Bajaj Finance, Infosys, Alembic Pharma, IndiaMART, Schaeffler India, CEAT in focus after key updates - Business Upturn
- 26 days ago - Alembic Pharmaceuticals gets USFDA final approval for Carbamazepine tablets USP 200 mg - Business Upturn
- 6 weeks ago - Alembic Pharmaceuticals gets USFDA final approval for Pantoprazole Sodium for Injection, 40 mg/vial - Business Upturn